Daniel R. Chevallard

Insider Reports History

Location
San Diego, CA
Signature
/s/ Daniel R. Chevallard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel R. Chevallard:

Company Role Class Num Shares Value Price $ Report Date Ownership
LENZ Therapeutics, Inc. Chief Financial Officer Common Stock 5,386 $122,564 $22.76 07 Nov 2025 Direct
Viracta Therapeutics, Inc. CFO and COO Common Stock 102,306 $74,908 $0.7322 27 Feb 2024 Direct
Viracta Therapeutics, Inc. CFO and COO Restricted Stock Units 34,444 $16,988 $0.4932 25 Feb 2024 Direct
Viracta Therapeutics, Inc. CFO and COO Stock Option (Right to Buy) 200,000 12 Mar 2024 Direct
LENZ Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 84,200 02 Jan 2026 Direct
LENZ Therapeutics, Inc. Chief Financial Officer Restricted Stock Unit 14,000 02 Jan 2026 Direct

Insider Reports Filed by Daniel R. Chevallard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LENZ LENZ Therapeutics, Inc. 02 Jan 2026 2 $0 4 Chief Financial Officer 06 Jan 2026, 16:21
LENZ LENZ Therapeutics, Inc. 07 Nov 2025 2 +$50,017 4 Chief Financial Officer 07 Nov 2025, 19:42
LENZ LENZ Therapeutics, Inc. 09 Jan 2025 1 $0 4 Chief Financial Officer 13 Jan 2025, 17:22
LENZ LENZ Therapeutics, Inc. 14 May 2024 1 +$49,988 4 Chief Financial Officer 15 May 2024, 16:13
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 1 $0 4 Chief Financial Officer 25 Mar 2024, 20:36
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 0 $0 3 Chief Financial Officer 25 Mar 2024, 20:20
VIRX Viracta Therapeutics, Inc. 12 Mar 2024 1 $0 4 CFO and COO 13 Mar 2024, 20:29
VIRX Viracta Therapeutics, Inc. 25 Feb 2024 3 -$2,493 4 CFO and COO 27 Feb 2024, 19:54
VIRX Viracta Therapeutics, Inc. 25 Nov 2023 3 -$1,860 4 CFO and COO 28 Nov 2023, 19:06
VIRX Viracta Therapeutics, Inc. 25 Aug 2023 3 -$5,092 4 CFO and COO 29 Aug 2023, 18:47
VIRX Viracta Therapeutics, Inc. 25 May 2023 3 -$5,160 4 CFO and COO 26 May 2023, 19:29
VIRX Viracta Therapeutics, Inc. 16 Mar 2023 1 $0 4 CFO and COO 17 Mar 2023, 16:57
VIRX Viracta Therapeutics, Inc. 25 Feb 2023 3 -$6,051 4 CFO and COO 28 Feb 2023, 17:22
VIRX Viracta Therapeutics, Inc. 25 Nov 2022 3 -$9,606 4 CFO and COO 29 Nov 2022, 16:33
VIRX Viracta Therapeutics, Inc. 25 Aug 2022 3 -$14,679 4 CFO and COO 29 Aug 2022, 21:14
VIRX Viracta Therapeutics, Inc. 25 May 2022 3 -$6,836 4 CFO and COO 27 May 2022, 17:27
VIRX Viracta Therapeutics, Inc. 17 Mar 2022 1 $0 4 CFO and COO 18 Mar 2022, 17:35
VIRX Viracta Therapeutics, Inc. 25 Feb 2022 3 -$11,112 4 CFO and COO 01 Mar 2022, 20:10
VIRX Viracta Therapeutics, Inc. 25 Nov 2021 4 -$36,464 4 CFO and COO 29 Nov 2021, 18:48
VIRX Viracta Therapeutics, Inc. 28 Sep 2021 2 +$9,000 4 CFO and COO 29 Sep 2021, 18:04
VIRX Viracta Therapeutics, Inc. 28 May 2021 2 +$10,800 4 CFO and COO 01 Jun 2021, 17:49